Suppr超能文献

肉豆蔻酸异丙酯对依托泊苷从聚乳酸-羟基乙酸共聚物微球中的物理特性及体外释放的影响

Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

作者信息

Schaefer M J, Singh J

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, North Dakota State University, Fargo, ND 58105, USA.

出版信息

AAPS PharmSciTech. 2000 Nov 13;1(4):E32. doi: 10.1208/pt010432.

Abstract

The purpose of this paper was to study the effect of the isopropyl myristic acid ester (IPM) on the physicochemical characteristics of etoposide-loaded poly(lactic-co-glycolic acid) (PLGA) microspheres-specifically, the effects on the size and drug loading of the microspheres, the polymer matrix and surface morphology, and the release of etoposide from the microspheres. The experiment was structured to examine 2 IPM concentrations (25% and 50%) and 1 control (no IPM) at 2 different etoposide-loading percentages (10% and 5%). The microspheres were prepared using a single-emulsion solvent-extraction procedure. Samples from each batch of microspheres were then analyzed for size distribution, drug-loading efficiency, surface characteristics, in vitro release, and in vitro microsphere degradation. The incorporation of 50% IPM significantly increased (P <.05) the size of the microspheres when compared with the control and 25% IPM microspheres. However, incorporation of 25% or 50% IPM did not change (P >.05) the drug-loading efficiency in comparison with the microspheres prepared without IPM. The microspheres containing 50% IPM were shown to significantly increase (P <.05) the release of etoposide from the microspheres at both etoposide concentrations. The microspheres prepared incorporating 25% IPM and 5% etoposide increased the in vitro release (P <.05) in comparison with the microspheres prepared without IPM. The 5% etoposide-PLGA microspheres showed a smooth, nonporous surface that changed to a dimpled, nonporous surface after addition of 25% IPM. During the in vitro degradation study, the IPM-containing microspheres slowly became porous but retained their structural integrity throughout the experiment.

摘要

本文旨在研究肉豆蔻酸异丙酯(IPM)对载有依托泊苷的聚乳酸-乙醇酸共聚物(PLGA)微球物理化学特性的影响,具体包括对微球尺寸、载药量、聚合物基质和表面形态的影响,以及依托泊苷从微球中的释放情况。实验设计了2种IPM浓度(25%和50%)和1个对照组(无IPM),依托泊苷的载药百分比有2种(10%和5%)。微球采用单乳液溶剂萃取法制备。然后对每批微球样品进行尺寸分布、载药效率、表面特性、体外释放和体外微球降解分析。与对照组和含25% IPM的微球相比,加入50% IPM显著增加了微球尺寸(P <.05)。然而,与未添加IPM制备的微球相比,加入25%或50% IPM并未改变载药效率(P >.05)。在两种依托泊苷浓度下,含50% IPM的微球均显示出依托泊苷从微球中的释放显著增加(P <.05)。与未添加IPM制备的微球相比,加入25% IPM和5%依托泊苷制备的微球体外释放增加(P <.05)。5%依托泊苷-PLGA微球表面光滑无孔,加入25% IPM后变为有凹坑的无孔表面。在体外降解研究中,含IPM的微球逐渐变得多孔,但在整个实验过程中保持其结构完整性。

相似文献

2
Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
Biomaterials. 2002 Aug;23(16):3465-71. doi: 10.1016/s0142-9612(02)00053-4.
3
Effect of additives on stability of etoposide in PLGA microspheres.
Drug Dev Ind Pharm. 2001 Apr;27(4):345-50. doi: 10.1081/ddc-100103734.
7
Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Drug Deliv. 2014 May;21(3):185-92. doi: 10.3109/10717544.2013.840813. Epub 2013 Oct 10.

引用本文的文献

4
Development and evaluation of sustained-release etoposide-loaded poly(ε-caprolactone) implants.
AAPS PharmSciTech. 2013 Jun;14(2):890-900. doi: 10.1208/s12249-013-9977-6. Epub 2013 May 11.
5
Ethylcellulose-based matrix-type microspheres: influence of plasticizer RATIO as pore-forming agent.
AAPS PharmSciTech. 2011 Dec;12(4):1127-35. doi: 10.1208/s12249-011-9680-4. Epub 2011 Sep 2.
6
Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation.
AAPS PharmSciTech. 2011 Jun;12(2):650-7. doi: 10.1208/s12249-011-9619-9. Epub 2011 May 12.
7
Formulation and evaluation of mucoadhesive glipizide microspheres.
AAPS PharmSciTech. 2005 Sep 20;6(1):E49-55. doi: 10.1208/pt060110.
8
Effect of additives on the release of a model protein from PLGA microspheres.
AAPS PharmSciTech. 2001 Dec 17;2(4):30. doi: 10.1208/pt020430.

本文引用的文献

3
A novel in vitro release technique for peptide containing biodegradable microspheres.
AAPS PharmSciTech. 2000 Mar 9;1(1):E4. doi: 10.1208/pt010104.
5
Etoposide: four decades of development of a topoisomerase II inhibitor.
Eur J Cancer. 1998 Sep;34(10):1514-21. doi: 10.1016/s0959-8049(98)00228-7.
6
Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.
Drug Dev Ind Pharm. 1998 Aug;24(8):703-27. doi: 10.3109/03639049809082719.
9
Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
Biomaterials. 1995 Oct;16(15):1123-30. doi: 10.1016/0142-9612(95)93575-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验